Annamaria Gullà, MD, of Dana Farber Cancer Institute, was presented with the 2020 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award is presented to the ASH Scholar Award recipient with the highest-scoring abstract at the ASH annual meeting, as determined by the appointed abstract reviewers. It honors the memory and legacy of Dr. Joanne Levy, who passed away in 2004. Dr. Levy was a past Scholar Award recipient and a respected ASH member. She graduated from Harvard Medical School and went on to receive many esteemed awards and honors, including the ASH Junior Faculty Scholar Award in 2000. The Joanne Levy Memorial Award is made possible by the Levy family to continue her legacy and promote excellence in hematology research.
Dr. Gullà is a research fellow in the Department of Medical Oncology, Division of Hematologic Neoplasia, at Dana Farber Cancer Institute. Dr. Gullà views this award as a steppingstone in her research career. “I am honored to be recognized by the hematology community to receive the prestigious Joanne Levy, MD, Memorial Award,” she said. “As an ASH Scholar and early-career cancer scientist, this award represents a true morale booster for my work and my career toward independence,” she added.
Dr. Gullà will present her oral abstract 665 titled, “Bortezomib Induces Anti-Multiple Myeloma Immune Response Mediated By Cgas/Sting Pathway Activation, Type I Interferon Secretion, and Immunogenic Cell Death: Clinical Application,” (Session 652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy) Monday, December 7, at 11:30 a.m. Pacific time (available later on-demand).